Bellerophon Therapeutics Buy Hold or Sell Recommendation
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Bellerophon Therapeutics is 'Not Rated'. The recommendation algorithm takes into account all of Bellerophon Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. In addition, we conduct extensive research on individual companies such as Bellerophon and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bellerophon Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Bellerophon |
Execute Bellerophon Therapeutics Buy or Sell Advice
The Bellerophon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bellerophon Therapeutics. Macroaxis does not own or have any residual interests in Bellerophon Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bellerophon Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Bellerophon Therapeutics Trading Alerts and Improvement Suggestions
| Bellerophon Therapeutics is not yet fully synchronised with the market data | |
| Bellerophon Therapeutics has some characteristics of a very speculative penny stock | |
| Bellerophon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (19.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bellerophon Therapeutics currently holds about 16.33 M in cash with (17.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Bellerophon Therapeutics Returns Distribution Density
The distribution of Bellerophon Therapeutics' historical returns is an attempt to chart the uncertainty of Bellerophon Therapeutics' future price movements. The chart of the probability distribution of Bellerophon Therapeutics daily returns describes the distribution of returns around its average expected value. We use Bellerophon Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bellerophon Therapeutics returns is essential to provide solid investment advice for Bellerophon Therapeutics.
| Mean Return | -2.09 | Value At Risk | -14.34 | Potential Upside | 7.64 | Standard Deviation | 12.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bellerophon Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Parag Shah of 50000 shares of Bellerophon Therapeutics subject to Rule 16b-3 [view details]
Bellerophon Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bellerophon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bellerophon Therapeutics Buy or Sell Advice
When is the right time to buy or sell Bellerophon Therapeutics? Buying financial instruments such as Bellerophon Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bellerophon Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |